LivaNova PLC (LIVN)-医療機器分野:企業M&A・提携分析

◆英語タイトル:LivaNova PLC (LIVN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010985
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:75
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
LivaNova PLC (LivaNova) is a medical technology company that offers medical devices for cardiac surgery, neuromodulation and cardiac rhythm management. The company’s neuromodulation segment provides vagus nerve stimulation therapy system, an implantable device for the people affected by treatment-resistant epilepsy, depression, heart failure and other chronic disorders. Its cardiovascular surgery products include oxygenators, heart-lung machines, perfusion tubing systems, cannulae and accessories; systems for autotransfusion and autologous blood washing; surgical tissue and mechanical valve replacements, and repair products for damaged or diseased heart valves. LivaNova offers cardiac rhythm management products such as implantable cardiac pacemakers, cardioverter defibrillators, cardiac resynchronization therapy devices, and patient management tools. The company offers its solutions to patients, healthcare professionals and healthcare systems. LivaNova is headquartered in London, the UK.

LivaNova PLC (LIVN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
LivaNova PLC , Medical Equipment, Deals By Year, 2011 to YTD 2017 6
LivaNova PLC , Medical Equipment Deals By Type, 2011 to YTD 2017 7
LivaNova PLC , Medical Equipment, Deals By Region, 2011 to YTD 2017 8
LivaNova PLC , Medical Equipment, Deals By Market, 2011 to YTD 2017 9
LivaNova PLC , Medical Equipment, Deals Summary, 2011 to YTD 2017 10
LivaNova PLC , Medical Equipment, Deal Details 11
Venture Financing 11
HighLife Raises USD12.3 Million in Venture Financing 11
MD Start Secures USD11.5 Million in Venture Funding 12
IMTHERA MEDICAL Secures US$4 Million In Series C Venture Financing 13
Partnerships 14
Cyberonics Enters Into Licensing Agreement With Imricor Medical Systems For Novel MRI Compatibility Lead Technology 14
Merger 15
Sorin Merges with Cyberonics for USD2.7 Billion 15
Asset Transactions 17
MicroPort Scientific to Acquire Cardiac Rhythm Management Business Franchise from LivaNova 17
Acquisition 18
LivaNova to Acquire ImThera Medical for Upto USD225 Million 18
LivaNova Acquires Remaining 51% Stake in Caisson Interventional 19
Mittel Plans to Sell 6% Interest in LivaNova 20
NorthCoast Asset Management Divests Stake in Cyberonics 21
Cyberonics Acquires Minority Stake In cerbomed, Provider Of Neuro-Therapy Solutions, For US$2.6 Million 22
LivaNova PLC – Key Competitors 23
LivaNova PLC – Key Employees 24
LivaNova PLC – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 27
Strategy And Business Planning 27
Jul 06, 2016: LivaNova Sets Operating Model and Supporting Organization 27
Financial Announcements 28
Nov 02, 2017: LivaNova Reports Third Quarter 2017 Results 28
Aug 09, 2017: LivaNova Reports Second Quarter 2017 Results 30
May 03, 2017: LivaNova Reports First Quarter 2017 Results 32
Mar 31, 2017: LivaNova Reiterates Full-Year 2017 Guidance 34
Mar 01, 2017: LivaNova Reports Fourth Quarter and Full-Year 2016 Results 35
Nov 02, 2016: LivaNova Reports Third Quarter 2016 Results 38
Sep 29, 2016: LivaNova Announces Half-Year Financial Report 40
Aug 03, 2016: LivaNova Reports Second Quarter 2016 Results 47
May 04, 2016: LivaNova Reports First Quarter 2016 Results 49
Feb 24, 2016: LivaNova Reports 2015 Annual and Fourth Quarter Financial Results 51
Corporate Communications 54
Jun 12, 2017: LivaNova Appoints Keyna Skeffington as Senior Vice President and General Counsel 54
May 16, 2017: LivaNova Announces Thad Huston as Chief Financial Officer 55
Mar 31, 2017: LivaNova Announces Chief Financial Officer Resignation 56
Nov 02, 2016: LivaNova Announces CEO Transition: Damien McDonald to Succeed Andre-Michel Ballester 57
Aug 01, 2016: LivaNova Names Chief Operating Officer 58
Jul 28, 2016: LivaNova Names Andrea L. Saia to its Board of Directors 59
Mar 03, 2016: LivaNova Announces Appointment of Vice President Investor Relations and Corporate Communications 60
Jan 13, 2016: LivaNova Announces Management Change 61
Legal and Regulatory 62
Jun 21, 2017: VNS Therapy Receives FDA Approval for Expanded MRI Labeling 62
Feb 23, 2017: LivaNova Announces Its Intent to Delist from London Stock Exchange 63
Jan 05, 2016: LivaNova Provides Update on FDA Warning Letter 64
Product News 65
Sep 22, 2016: LivaNova Launches Next Generation ICD and CRT-D Devices in the United States 65
03/08/2016: LivaNova Announces the First U.S. Implants of Perceval, the Only Sutureless Valve for Aortic Valve Replacement Surgery 66
02/29/2016: LivaNova Receives Regulatory Approval in Japan for the Solo Smart Stentless Tissue Aortic Valve 67
02/01/2016: LivaNova Announces FDA Approval of Stented Heart Valve CROWN PRT for Aortic Valve Disease 68
01/28/2016: LivaNova Receives Regulatory Approval in Japan for KORA 250 69
Product Approvals 70
Feb 29, 2016: LivaNova Receives Regulatory Approval in Japan for the Solo Smart Stentless Tissue Aortic Valve 70
Feb 01, 2016: LivaNova Announces FDA Approval of Stented Heart Valve CROWN PRT for Aortic Valve Disease 71
Jan 28, 2016: LivaNova Receives Regulatory Approval in Japan for KORA 250 72
Other Significant Developments 73
Sep 14, 2017: LivaNova to Explore Strategic Options for Cardiac Rhythm Management Business Franchise 73
Aug 07, 2017: LivaNova Implements 3T Heater-Cooler Device Modification 74
Appendix 75
Methodology 75
About GlobalData 75
Contact Us 75
Disclaimer 75

List of Tables
LivaNova PLC , Medical Equipment, Key Facts, 2016 2
LivaNova PLC , Medical Equipment, Deals Summary, 2011 to YTD 2017 2
LivaNova PLC , Medical Equipment, Deals By Year, 2011 to YTD 2017 6
LivaNova PLC , Medical Equipment Deals By Type, 2011 to YTD 2017 7
LivaNova PLC , Medical Equipment, Deals By Region, 2011 to YTD 2017 8
LivaNova PLC , Deals By Market, 2011 to YTD 2017 9
LivaNova PLC , Medical Equipment, Deals Summary, 2011 to YTD 2017 10
HighLife Raises USD12.3 Million in Venture Financing 11
MD Start Secures USD11.5 Million in Venture Funding 12
IMTHERA MEDICAL Secures US$4 Million In Series C Venture Financing 13
Cyberonics Enters Into Licensing Agreement With Imricor Medical Systems For Novel MRI Compatibility Lead Technology 14
Sorin Merges with Cyberonics for USD2.7 Billion 15
MicroPort Scientific to Acquire Cardiac Rhythm Management Business Franchise from LivaNova 17
LivaNova to Acquire ImThera Medical for Upto USD225 Million 18
LivaNova Acquires Remaining 51% Stake in Caisson Interventional 19
Mittel Plans to Sell 6% Interest in LivaNova 20
NorthCoast Asset Management Divests Stake in Cyberonics 21
Cyberonics Acquires Minority Stake In cerbomed, Provider Of Neuro-Therapy Solutions, For US$2.6 Million 22
LivaNova PLC , Key Competitors 23
LivaNova PLC , Key Employees 24
LivaNova PLC , Subsidiaries 25

★海外企業調査レポート[LivaNova PLC (LIVN)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Journey Energy Inc (JOY):石油・ガス:M&Aディール及び事業提携情報
    Summary Journey Energy Inc (Journey Energy), a subsidiary of Maples Investments LP, is an oil and gas company that offers exploration, development and production oil and natural gas assets. The company provides horizontal and multi-frac drilling, and secondary recovery methods that helps in acquirin …
  • Oval Medical Technologies Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Oval Medical Technologies Ltd (Oval Medical), a subsidiary of SMC Ltd, is a developer of patient-centric autoinjectors. The company offers cyclic olefin polymeric (COP) drug containers, which are injection moulded for customization. Based on its subcutaneous platform, the company is developi …
  • Atkore International Group Inc. (ATKR):企業の財務・戦略的SWOT分析
    Atkore International Group Inc. (ATKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Swallowfield PLC:企業の戦略・SWOT・財務情報
    Swallowfield PLC - Strategy, SWOT and Corporate Finance Report Summary Swallowfield PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Accrol Group Holdings PLC (ACRL):企業の財務・戦略的SWOT分析
    Accrol Group Holdings PLC (ACRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • CF Industries Holdings, Inc:企業のM&A・事業提携・投資動向
    CF Industries Holdings, Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CF Industries Holdings, Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • EXOR SpA:戦略・SWOT・企業財務分析
    EXOR SpA - Strategy, SWOT and Corporate Finance Report Summary EXOR SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Camel-IDS NV:製薬・医療:M&Aディール及び事業提携情報
    Summary Camel-IDS NV (Camel-IDS) is a biotechnology company that develops radio-immunotherapeutic drugs for cancer patients. The company offers developing of compound radiopharmaceutical drugs for treatment of Her2 positive cancer. Its technology platform is based on recombinant, small antigen-bindi …
  • IGas Energy PLC (IGAS):石油・ガス:M&Aディール及び事業提携情報
    Summary IGas Energy PLC (IGas) is an oil and gas company that explores, develops and produces onshore oil and natural gas properties. The company extracts oil and gas trapped underground in basins. It develops and produces gas and oil reserves in the North West of England, the East Midlands, the Wea …
  • GSI Creos Corporation:企業の戦略・SWOT・財務情報
    GSI Creos Corporation - Strategy, SWOT and Corporate Finance Report Summary GSI Creos Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Merge Healthcare Incorporated:企業のM&A・事業提携・投資動向
    Merge Healthcare Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Merge Healthcare Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Kuwait Gulf Oil Co:企業の戦略的SWOT分析
    Kuwait Gulf Oil Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Davos Life Science Pte Ltd:企業の戦略・SWOT・財務情報
    Davos Life Science Pte Ltd - Strategy, SWOT and Corporate Finance Report Summary Davos Life Science Pte Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Valmet Corp (VALMT):企業の財務・戦略的SWOT分析
    Valmet Corp (VALMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Marsulex Environmental Technologies Corp:企業の戦略的SWOT分析
    Marsulex Environmental Technologies Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Advance Auto Parts, Inc.:企業の戦略・SWOT・財務分析
    Advance Auto Parts, Inc. - Strategy, SWOT and Corporate Finance Report Summary Advance Auto Parts, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • MADO Ice Cream & Foodstuffs Co., Ltd.:企業の戦略・SWOT・財務分析
    MADO Ice Cream & Foodstuffs Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary MADO Ice Cream & Foodstuffs Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Clean TeQ Holdings Ltd (CLQ):企業の財務・戦略的SWOT分析
    Summary Clean TeQ Holdings Ltd (Clean TeQ) is a clean technology company that offers air pollution control solutions using biotechnology-based processes. The company provides water treatment products such as advanced separations, advanced oxidation, encapsulated bacteria, continuous ionic filtration …
  • Pets at Home Group Plc:戦略・SWOT・企業財務分析
    Pets at Home Group Plc - Strategy, SWOT and Corporate Finance Report Summary Pets at Home Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • First Abu Dhabi Bank (FAB):企業の財務・戦略的SWOT分析
    First Abu Dhabi Bank (FAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆